C are repaired by the AfAlkA base excision repair glycosylase of Archaeoglobus fulgidus, suggesting a different repair mechanism for these lesions in the third domain of life. In addition, AfAlkA was found to effect a robust excision of 1,N 6 -ethenoadenine. We present a high-resolution crystal structure of AfAlkA, which, together with the characterization of several sitedirected mutants, forms a molecular rationalization for the newly discovered base excision activity.
Nitric oxide (
NO
) produced by mammalian nitric oxide synthases (
mNOS
s) is an important mediator in a variety of physiological functions. Crystal structures of
mNOS
s have shown strong conservation of the active‐site residue Val567 (numbering for rat neuronal
NOS
,
nNOS
).
NOS
‐like proteins have been identified in several bacterial pathogens, and these display striking sequence identity to the oxygenase domain of
mNOS
(
NOS
oxy), with the exception of a Val to Ile mutation at the active site. Preliminary studies have highlighted the importance of this Val residue in
NO
‐binding, substrate recognition, and oxidation in
mNOS
s. To further elucidate the role of this valine in substrate and substrate analogue recognition, we generated five Val567 mutants of the oxygenase domain of the neuronal
NOS
(
nNOS
oxy) and used UV‐visible and
EPR
spectroscopy to investigate the effects of these mutations on the heme distal environment, the stability of the heme‐Fe
II
‐
CO
complexes, and the binding of a series of substrate analogues. Our results are consistent with Val567 playing an important role in preserving the integrity of the active site for substrate binding, stability of heme‐bound gaseous ligands, and potential
NO
production.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.